Evidence map›Paper›PMID 39923077›Full record

ArticleOrphanet journal of rare diseases2025

Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden.

Cristina Bulai Livideanu, Jérémy Gottlieb, Denis Jullien, Thierry Passeron, Sophie Vildy, Emmanuel Delaporte, Carle Paul, Julien Chollet, Marie Najean, Denis San and 5 more

Abstract readMulticenter StudyLetter
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Cristina Bulai LivideanuDepartment of Dermatology, Hôpital Larrey, Toulouse University Hospital, Toulouse, France.
Jérémy GottliebDepartment of Dermatology, Niort, CH, France.
Denis JullienDepartment of Dermatology, Faculty of Medicine Lyon-Est, Hôpital Edouard Herriot, University of Lyon, Lyon, France.
Thierry PasseronDepartment of Dermatology, Université Côte D'Azur, Centre Hospitalier Universitaire Nice, Nice, France.
Sophie VildyDepartment of Dermatology, Hôpital privé du Confluent, Nantes, 44200, France.
Emmanuel DelaporteDepartment of Dermatology, Aix Marseille University, APHM, North Hospital, Marseille, France.
Carle PaulDepartment of Dermatology, Niort, CH, France.
Julien CholletBoehringer Ingelheim France, Paris, France.
Marie NajeanBoehringer Ingelheim France, Paris, France.
Denis SanBoehringer Ingelheim France, Paris, France.
Charles TaiebPatients priority, EMMA, Paris, France. Charles.taieb@emma.clinic.
Bénédicte CharlesFrance psoriasis, Paris, France.
Emmanuel MaheDepartment of Dermatology, Hôpital Victor Dupouy, 69 rue du Lieutenant-Colonel Prud'hon, Argenteuil, 95100, France.
Pierre-André BecherelDermatology Department, Private Hospital Antony, Paris, France.
Laurent MiseryUniv Brest, LIEN, Brest, France.

Funding

Boehringer Ingelheim France Boehringer Ingelheim France
6 · The paper itself

Abstract

The objective of this study was to assess the demographic characteristics and impact on quality of life (QoL) of patients with PPG in France through a multicentre study. The results of the study are as follows: The PRO [PUSH-D, PHQ-9 et GAD-7] revealed that more than half of the patients exhibited a significant impact on their quality of life. High scores for fatigue, stress, skin and joint pain were reported, with 65% of patients at risk of mild to severe depression. The clinical burden was also assessed. A total of 48.8% of patients were hospitalised, while 39% took sick leave. This study is the first to assess the PUSH-D, PHQ-9 and GAD-7 scores in patients with PPG, which highlighted a significant clinical burden and negative impact on their daily lives.

Indexed as

PsoriasisAdultAgedDepressionFemaleFranceHumansMaleMiddle AgedQuality of LifeBurdenGeneralized Pustular PsoriasisQuality of lifeStigmatization

Identifiers

PMID39923077
PMCPMC11806833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.